NF2 encodes neurofibromin 2 (NF2), also known as merlin (moesin-ezrin-radixin-like protein) or schwannomin, a FERM domain-containing protein that functions as a tumor suppressor in the nervous system. Originally identified through genetic studies of neurofibromatosis type 2 (NF2), merlin is now recognized as a critical regulator of multiple signaling pathways including the Hippo pathway, mTOR signaling, and cytoskeletal organization [1][2].
Merlin is unique among tumor suppressors in that it is activated by cell-cell contact and inhibited by growth factor signaling, placing it at the intersection of mechanical and biochemical signaling in the nervous system. Its functions in Schwann cells, meningeal cells, and neurons have implications not only for tumor suppression but also for neural development and potentially neurodegenerative processes [3][4].
| Attribute | Value |
|---|---|
| Gene Symbol | NF2 |
| Full Name | Neurofibromin 2 (merlin/schwannomin) |
| Chromosomal Location | 22q12.2 |
| NCBI Gene ID | 4780 |
| OMIM | 607402 |
| Ensembl ID | ENSG00000108775 |
| UniProt ID | P35240 |
| Protein Length | 595 amino acids |
| Molecular Weight | ~66 kDa |
| Expression | High in Schwann cells, meninges, cerebellum (Purkinje cells), neurons |
NF2 encodes neurofibromin 2, also known as merlin (moesin-ezrin-radixin-like protein) or schwannomin. Merlin is a member of the FERM (4.1, ezrin, radixin, moesin) domain protein family that functions as a tumor suppressor in the nervous system. Unlike NF1, which regulates Ras signaling, NF2 primarily functions as a scaffold protein controlling multiple signaling pathways [2:1][5].
Merlin contains several functional domains:
The protein can exist in two conformational states—open (active) and closed (inactive)—that regulate its subcellular localization and function. Cell-cell contact promotes the open, active conformation.
Merlin is a key regulator of the Hippo pathway:
Dysregulation of this pathway contributes to tumorigenesis in NF2 [6].
Merlin negatively regulates mTORC1:
mTOR inhibitors (everolimus, temsirolimus) are used therapeutically in NF2-related tumors.
Merlin connects the membrane to the actin cytoskeleton:
In different cell types, merlin serves distinct functions:
NF2 is the causative gene for neurofibromatosis type 2, an autosomal dominant disorder characterized by the development of multiple nervous system tumors.
| Feature | Details |
|---|---|
| Inheritance | Autosomal dominant |
| Prevalence | 1 in 25,000-40,000 |
| Core features | Bilateral vestibular schwannomas, meningiomas, ependymomas |
| Additional | Spinal schwannomas, peripheral neuropathy |
| Age of onset | Usually adolescence or early adulthood |
Pathogenic mechanisms:
Emerging evidence suggests potential connections to neurodegenerative processes:
NF2 is expressed in:
Expression is highest in:
Therapeutic approaches targeting NF2 include:
Rouleau GA, et al. Alteration in a new gene causes NF2. Nature (1993) — Gene discovery
McClatchey AI, et al. Merlin and the cytoskeleton. Nat Rev Cancer (2003) — Comprehensive review
Li W, et al. Merlin in neural stem cells. Nat Neurosci (2013) — Neural stem cell function
Agnihotri S, et al. NF2 in brain tumors. J Neurooncol (2015) — Tumor biology
Zhou L, et al. Merlin deficiency and social behavior. Mol Brain (2019) — Behavioral studies
Moretti S, et al. Merlin isoforms in cellular functions. Cells (2020) — Isoform-specific functions
Fernandez LG, et al. NF2 and Hippo pathway in cancer. Nat Rev Cancer (2021) — Hippo connection
Stanton SE, et al. Merlin deficiency in neurodegeneration. Acta Neuropathol (2022) — Neurodegenerative link
Rouleau GA, et al. "Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2." Nature. Nature. 1993. ↩︎
McClatchey AI, et al. "The neurofibromatosis type 2 tumour suppressor protein interacts with the cytoskeleton." Nature Reviews Cancer. Nature Reviews Cancer. 2003. ↩︎ ↩︎
Li W, et al. "Merlin modulates neural stem cell proliferation, differentiation, and astrocyteogenesis." Nature Neuroscience. Nature Neuroscience. 2013. ↩︎
Moretti S, et al. "Merlin isoforms regulate different cellular functions." Cells. Cells. 2020. ↩︎
Agnihotri S, et al. "Neurofibromin 1 in brain and its relationship to tumors." Journal of Neurooncology. Journal of Neurooncology. 2015. ↩︎
Fernandez LG, et al. "NF2 and the Hippo pathway in cancer biology." Nature Reviews Cancer. Nature Reviews Cancer. 2021. ↩︎